Oxford Nanopore Technologies Plc - Company Profile

Powered by

All the sales intelligence you need on Oxford Nanopore Technologies Plc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Oxford Nanopore Technologies Plc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Oxford Nanopore Technologies Plc.

Back to companies

Oxford Nanopore Technologies Plc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

Oxford Nanopore Technologies Plc (Oxford Nanopore) specializes in the development of DNA/RNA sequencing technology. The company develops sequencing devices that offer real-time analysis and scalable formats for various applications. The company’s products include Flongle, MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecules and other types of molecules. Its products find applications in various areas of research such as microbiology, basic genome research, human genetics, cancer research, environmental research, microbiome, clinical research, population genomics, plant research, transcriptome analysis and animal research. The company also offers support, certification and training services. The company has business operations into the Uk, the US, China and Japan. Oxford Nanopore is headquartered in Oxford, Greater London, the UK.

 Gain a 360-degree view of Oxford Nanopore Technologies Plc and make more informed decisions for your business Gain a 360-degree view of Oxford Nanopore Technologies Plc and make more informed decisions for your business Learn more
Headquarters United Kingdom
Address Gosling Building, Edmund Halley Road, Oxford Science Park, Greater London, OX44DQ
Website www.nanoporetech.com
Telephone 44 34354 90066
No of Employees 1,300
Industry Medical Equipment
Ticker Symbol & Exchange ONT (LON)
Revenue (2024) $295.0M 22.2% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ 0.7% (2024 vs 2023)
Market Cap* $1.5B
Net Profit Margin (2024) XYZ 18.7% (2024 vs 2023)
* As of and is in US$
View Oxford Nanopore Technologies Plc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Oxford Nanopore Technologies Plc premium industry data and analytics

7

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Oxford Nanopore Technologies Plc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
MinION - -
Gridion-X5 Support AmplideX
PromethION Training
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Oxford Nanopore Technologies Plc portfolio and identify potential areas for collaboration Understand Oxford Nanopore Technologies Plc portfolio and identify potential areas for collaboration Learn more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2026 Contracts/Agreements In April, the company and Cepheid expanded their partnership to develop a rapid workflow for identifying bacterial and fungal pathogens.
2026 Contracts/Agreements In March, the company entered into a collaboration with A.D.A.M. Innovations to develop and deploy advanced genomic sequencing and medicine applications based on comprehensive, nanopore sequencing in Japan.
2026 New Products/Services In March, the company launched world’s first GMP-validated adventitious viral agent (AVA) detection test based on Oxford Nanopore sequencing.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Image for loader

Competitor Comparison

Key Parameters Oxford Nanopore Technologies Plc Quest Diagnostics Inc Illumina Inc Exact Sciences Corp Adaptive Biotechnologies Corp
Headquarters United Kingdom United States of America United States of America United States of America United States of America
City Oxford Secaucus San Diego Madison Seattle
State/Province Greater London New Jersey California Wisconsin Washington
No. of Employees 1,300 46,000 8,600 7,200 624
Entity Type Public Public Public Private Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Duncan Eden Tatton-Brown Chairman Executive Board 2022 61
Francis Albert Luc Van Parys Chief Executive Officer; Director Executive Board 2026 51
Nicholas Patrick Keher Chief Financial Officer; Director Executive Board 2024 44
Tim Cowper Chief Operating Officer Senior Management 2024 61
Lakmal Jayasinghe Chief Scientific Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Oxford Nanopore Technologies Plc key executives to enhance your sales strategy Gain insight into Oxford Nanopore Technologies Plc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?